ROCHE WN42171
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
An open-label, multicenter, rollover study to evaluate the safety, tolerability, and efficacy of long-term gantenerumab administration in participants with Alzheimer’s disease.
